TrialAnnals of surgical oncology2026

Efficacy of Bidirectional Paclitaxel plus Capecitabine or Nilotinib for Peritoneal Carcinomatosis: A Single Institution Analysis of Two Phase II Clinical Trials.

Amber F Gallanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.